Chart analyst David Keller looks at the technical backdrop for this name that's broken above its 200-day moving average.
Get this delivered to your inbox, and more info about our products and services.
Baird's new $210 price target implies a potential upside of 33% ahead for Albemarle.
A battery stock is perking up, and the charts suggest a run to the highs may be in the cards.
Chart analyst Frank Cappelleri breaks down the technical outlook on the biotech stock.
Several factors indicate this industrial giant could see a meaningful move higher, according to the charts.
David Keller breaks down the technicals on this biotech giant.
Chart analyst Katie Stockton breaks down the technical outlook of this Chinese tech name.
